Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Ketanserin and Yohimbine

supplement:

Yohimbine

Research Papers that Mention the Interaction

Also, ketanserin further increased FBF after vasodilation of reflexly vasoconstricted fingers by the alpha 2-adrenoceptor antagonist, yohimbine , and phentolamine increased FBF during ketanserin infusions.
The American journal of physiology  •  1988  |  View Paper
On a background of treatment with the α2-adrenoceptors blocker yohimbine (0.5 mg/kg), mianserin, cyproheptadine, and ketanserin inhibited movement activity and significantly reduced the sensitivity of animals to audiogenic convulsions.
Neuroscience and Behavioral Physiology  •  2006  |  View Paper
ketanserin … yohimbine or rauwolscine antagonized the 5HT effects as expected from competition of all 4 drugs for a single class of receptors in pulmonary arteries.5.… low (≤ 10−7 mol/l) in humans to account for a contribution of the metabolite to the blockade of 5HT effects by ketanserin.
Naunyn-Schmiedeberg's Archives of Pharmacology  •  2004  |  View Paper
Combinations of rauwolscine or yohimbine with ketanserin antagonized the 5 HT effects as expected from competition of the 4 drugs for a single class of receptor.4.The evidence is consistent with an interaction of 5 HT, ketanserin, rauwolscine and yohimbine with 5 HT2 receptors.
Naunyn-Schmiedeberg's Archives of Pharmacology  •  2004  |  View Paper
Prazosin (0.1 microM) did not affect inhibition of the MSR but yohimbine (1 microM) blocked it as effectively as ketanserin.
Neuropharmacology  •  1993  |  View Paper
The responses after 5HT and NA stimulation were blocked to baseline levels after exposure to ketanserin (5HT2 receptor antagonist) and a combination of prazosin, yohimbine , and propranolol (α1, α2, and β adrenoceptor antagonists, respectively).
Glia  •  1992  |  View Paper
This response to yohimbine (3 X 10(-7) M) was attenuated by 5-HT receptor antagonists such as 5-methoxygramine, methysergide and ketanserin.
Blood vessels  •  1985  |  View Paper
Thus, the abilities of yohimbine to inhibit and ketanserin to abolish cyclic flow reductions in stenosed canine coronary arteries suggest that serotonin and, possibly, alpha 2-adrenergic agonists may influence cyclic flow alterations importantly in this model.
Circulation research  •  1984  |  View Paper